Ahlqvist Mathias, Forsman Pär, Morberg Pål, Larsson Magnus, Broman Lars Mikael, Akram Shahzad
ECMO Center Karolinska, Pediatric Perioperative Medicine and Intensive Care, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Akademiska straket 14, Stockholm, 17176, Sweden.
Department of Research and Development, Capio Saint Göran Hospital, Stockholm, Sweden.
Eur J Trauma Emerg Surg. 2025 Jan 27;51(1):88. doi: 10.1007/s00068-024-02734-1.
Globally, trauma is a leading cause of death in young adults. The use of extracorporeal membrane oxygenation (ECMO) in the trauma population remains controversial due to the limited published research. This study aimed to analyze 30-day survival of all the trauma ECMO patients at our center, with respect to injury severity score (ISS) and new injury severity score (NISS).
We performed a retrospective analysis of all trauma patients receiving ECMO support at a Level 1 trauma center in Sweden between 1997 and 2019.
A total of 53 trauma patients received ECMO support. 85% were male; the median age was 24, with interquartile range (IQR) 17-44 years. More than 70% were multi-trauma patients. The mean NISS and ISS were 50 (IQR:34-57) and 42 (IQR:33-57), respectively. 62% were supported on veno-arterial ECMO with a survival benefit for veno-venous ECMO (75% vs. 36%, respectively (p = 0.01)). There was no association between severity in terms of trauma-score and survival. Sixteen patients (30%) were cannulated at referring hospitals and transported to our unit on ECMO with a survival of 69%, similar to those cannulated in-house. 60% of patients survived ECMO, and 51% survived to hospital discharge.
This study indicates that trauma patients may benefit from ECMO, independent of severity. Furthermore, our results support ECMO transport as feasible in trauma patients. We recommend larger multi-center studies to determine which trauma patients would have the greatest benefit of ECMO.
在全球范围内,创伤是青壮年死亡的主要原因。由于已发表的研究有限,体外膜肺氧合(ECMO)在创伤患者中的应用仍存在争议。本研究旨在分析我院所有创伤ECMO患者的30天生存率,并探讨损伤严重程度评分(ISS)和新损伤严重程度评分(NISS)与生存率的关系。
我们对1997年至2019年期间在瑞典一家一级创伤中心接受ECMO支持的所有创伤患者进行了回顾性分析。
共有53例创伤患者接受了ECMO支持。其中85%为男性;中位年龄为24岁,四分位间距(IQR)为17 - 44岁。超过70%为多发伤患者。平均NISS和ISS分别为50(IQR:34 - 57)和42(IQR:33 - 57)。62%的患者接受静脉 - 动脉ECMO支持,静脉 - 静脉ECMO组生存率更高(分别为75%和36%,p = 0.01)。创伤评分的严重程度与生存率之间无关联。16例患者(30%)在转诊医院插管并通过ECMO转运至我院,生存率为69%,与在我院插管的患者相似。60%的患者在ECMO支持下存活,51%的患者存活至出院。
本研究表明,创伤患者可能从ECMO中获益,与损伤严重程度无关。此外,我们的结果支持ECMO转运在创伤患者中是可行的。我们建议开展更大规模的多中心研究,以确定哪些创伤患者能从ECMO中获得最大益处。